PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
29-Jun-2020 JANSSEN EXPRESSES DISAPPOINTMENT WITH NICE FINAL APPRAISAL DOCUMENT DENYING MEN WITH AGGRESSIVE, EARLY PROSTATE CANCER ACCESS TO ZYTIGA® (ABIRATERONE ACETATE) JANSSEN
29-Jun-2020 Successful Elocta (Efmoroctocog alfa) bid means increased access for all people with haemophilia A in the UK SobiTM UK
29-Jun-2020 Berry Global to Supply Medicom in support of British Government’s Mask Manufacturing Mandate Medicom 
29-Jun-2020 Novartis response to NICE Appraisal Consultation Document (ACD) for Mayzent®▼ (siponimod) for the treatment of secondary progressive multiple sclerosis with active disease Novartis
29-Jun-2020 eConsult Online Triage Now Offered by 3,000 NHS GP Practices eConsult
29-Jun-2020 New online tool pinpoints HIV health inequalities in England to improve prevention and planning Gilead Sciences Ltd
29-Jun-2020 Thermo Fisher Scientific and Daiichi Sankyo to Co-Develop Global Companion Diagnostic for Patients with Non-Small Cell Lung Cancer Thermo Fisher Scientific
29-Jun-2020 Ege University improves patient access to leading-edge healthcare treatment options by joining Clinerion’s Patient Network Explorer platform. Clinerion Ltd.
28-Jun-2020 DuPont Achieves Non-GMO Certification for SeaGel®, Reinforces Commitment to Sustainable, Quality Ingredients DuPont
28-Jun-2020 Bacterial predator could help reduce COVID-19 deaths The University of Birmingham
28-Jun-2020 Bio-Gate signs cooperation agreement with Aesculap AG for coating revision implants Bio-Gate AG
28-Jun-2020 ReNeuron signs new exosome research collaboration ReNeuron Group plc
28-Jun-2020 Enterome completes €46.3 million ($52.6 million) financing to progress the clinical development of its therapeutic pipeline ENTEROME SA
28-Jun-2020 Sosei Heptares and AbbVie Announce New Discovery Collaboration Targeting Inflammatory Diseases AbbVie
28-Jun-2020 Chi-Med Announces US$100 Million Equity Investment by General Atlantic Chi-Med
28-Jun-2020 UK precision medicine company PrecisionLife identifies 68 genes associated with high risk of severe COVID-19, suggesting opportunities for genomic biomarkers and new treatment options PrecisionLife
28-Jun-2020 SNF472 Mechanism of Action data published in British Journal of Pharmacology Sanifit
25-Jun-2020 Panthera Biopartners appoints Chris Dodd as Executive VP of Business Development – Oncology and CNS Panthera Biopartners
25-Jun-2020 Panthera and Rutherford Health launch innovative oncology clinical trial network Panthera Biopartners
24-Jun-2020 Scenic Biotech Awarded €3.1 million Innovation Credit from Dutch Government to Progress CD47/QPCTL Immuno-oncology Program Scenic Biotech